Journal article
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, A Lugaresi, F Grand'Maison, R Hupperts, C Oreja-Guevara, R Bergamaschi, G Iuliano, R Alroughani, V Van Pesch, MP Amato, M Slee, F Verheul, R Fernandez-Bolanos, M Fiol, DL Spitaleri Show all
Brain | OXFORD UNIV PRESS | Published : 2013
DOI: 10.1093/brain/awt281
Abstract
The aim of this work was to evaluate sex differences in the incidence of multiple sclerosis relapses; assess the relationship between sex and primary progressive disease course; and compare effects of age and disease duration on relapse incidence. Annualized relapse rates were calculated using the MSBase registry. Patients with incomplete data or <1 year of follow-up were excluded. Patients with primary progressive multiple sclerosis were only included in the sex ratio analysis. Relapse incidences over 40 years of multiple sclerosis or 70 years of age were compared between females and males with Andersen-Gill and Tweedie models. Female-to-male ratios stratified by annual relapse count were e..
View full abstractRelated Projects (2)
Grants
Awarded by Multiple Sclerosis Research Australia
Funding Acknowledgements
The work was supported by the Multiple Sclerosis Research Australia Postdoctoral Fellowship to TK [11-054], NHMRC Career Development Award (Clinical) to H.B. [ID628856], NHMRC Project Grant [1032484], NHMRC Centre for Research Excellence [Grant ID 1001216] and the MSBase Foundation. The MSBase Foundation is a not-for-profit organization that receives support from Merck Serono, Biogen Idec, Novartis Pharma, Bayer-Schering, Sanofi-Aventis and BioCSL.